<?xml version="1.0" encoding="UTF-8"?>
<xml><bibliography><APA>Pinyada Wongnark และ Phannita Wattanaruengchai. (2024) Aprocitentan: A novel endothelin receptor antagonist in the treatment of resistant hypertension. &lt;i&gt;Isan Journal of Pharmaceutical Sciences&lt;/i&gt;, &lt;i&gt;20&lt;/i&gt;(3), 1-14.</APA><Chicago>Pinyada Wongnark และ Phannita Wattanaruengchai. "Aprocitentan: A novel endothelin receptor antagonist in the treatment of resistant hypertension". Isan Journal of Pharmaceutical Sciences  20 (2024):1-14.</Chicago><MLA>Pinyada Wongnark และ Phannita Wattanaruengchai. Aprocitentan: A novel endothelin receptor antagonist in the treatment of resistant hypertension. Faculty of Pharmaceutical Sciences KKU MSU UBU:ม.ป.ท. 2024.</MLA></bibliography></xml>
